- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharmaceuticals
Snapshot for Mylan Inc/PA (MYL)
| Open: | 31.8900 | Day's Range: | 31.1400 - 31.9200 | Volume: | 3,461,719 |
|---|---|---|---|---|---|
| Previous Close: | 31.8700 | 52wk Range: | 20.5000 - 32.2650 | 1-Yr Rtn: | +45.24% |
Key Statistics for MYL
| Current P/E Ratio (ttm) | 15.8282 |
|---|---|
| Estimated P/E(12/2013) | 10.9069 |
| Relative P/E vs. SPX | 0.9919 |
| Earnings Per Share (USD) (ttm) | 1.9756 |
| Est. EPS (USD) (12/2013) | 2.8670 |
| Est. PEG Ratio | 1.2296 |
| Market Cap (M USD) | 11,916.67 |
| Shares Outstanding (M) | 381.09 |
| 30 Day Average Volume | 4,761,701 |
| Price/Book (mrq) | 4.1493 |
| Price/Sale (ttm) | 1.8545 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | - |
| Last Dividend | 07/17/2007 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MYL
Company Profile & Key Executives for MYL
Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
| Robert J CouryChairman | Rodney L PiattVice Chairman |
| Heather BreschChief Executive Officer | Rajiv MalikPresident |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MYL News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page